Heart HealthTransthyretin Amyloid Cardiomyopathy
Patients with the A97S genotype of ATTR-CM may exhibit functional and structural improvements after tafamidis treatment. A recent case study showcased these potential benefits. Transthyretin amyloidosis cardiomyopathy (ATTR-CM) is an under-recognized cause of heart failure.…